Frontiers in Neuroscience Issue

May 21st 2020

Silvia Gatti-McArthur and colleagues have edited a research topic issue of Frontiers in Neuroscience entitled, Dopaminergic Alterations in Schizophrenia.

Topic editors: M.D. Tricklelbank, A.Grottick C.Tamminga, JC Martel PM Llorca and S. Gatti-McArthur

Schizophrenia is a disabling pathology with a lifetime prevalence of approximately 1% worldwide. The discovery of antipsychotics drugs that block the dopamine D2 receptor led to both improved disease management and to the dopamine hypothesis of schizophrenia, perhaps one of the most enduring in psychiatry. However, a clear understanding of the etiopathological mechanism(s) remains elusive. The contributions proposed for this Research Topic provide new paths for clinical and preclinical research.

Further information may be found at:

https://www.frontiersin.org/research-topics/8727/dopaminergic-alterations-in-schizophrenia